Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Limits to Natural Selection

Limits to Natural Selection

Organisms that are well-adapted to their environment are more likely to survive and reproduce. However, natural selection does not lead to perfectly adapted organisms. Several factors constrain natural selection.For one, natural selection can only act upon existing genetic variation. Hypothetically, redtusks may enhance elephant survival by deterring ivory-seeking poachers. However, if there are no gene variants—or alleles—for redtusks, natural selection cannot increase the prevalence of...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Global Regulatory Systems

Global Regulatory Systems

Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...

Dynamic Equilibrium

Dynamic Equilibrium

A reversible chemical reaction represents a chemical process that proceeds in both forward (left to right) and reverse (right to left) directions. When the rates of the forward and reverse reactions are equal, the concentrations of the reactant and product species remain constant over time and the system is at equilibrium. A special double arrow is used to emphasize the reversible nature of the reaction. The relative concentrations of reactants and products in equilibrium systems vary greatly;...

Woodward–Hoffmann Selection Rules and Microscopic Reversibility

Woodward–Hoffmann Selection Rules and Microscopic Reversibility

Electrocyclic reactions, cycloadditions, and sigmatropic rearrangements are concerted pericyclic reactions that proceed via a cyclic transition state. These reactions are stereospecific and regioselective. The stereochemistry of the products depends on the symmetry characteristics of the interacting orbitals and the reaction conditions. Accordingly, pericyclic reactions are classified as either symmetry-allowed or symmetry-forbidden. Woodward and Hoffmann presented the selection criteria for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Durability of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV).

Journal of medical virology·2025

Same author

Hemophagocytic Lymphohistiocytosis and Miliary Tuberculosis in an Apparently Immunocompetent Patient: A Case Report.

Infectious disease reports·2024

Same author

Systematic review and meta-analysis found that malnutrition was associated with poor cognitive development.

Acta paediatrica (Oslo, Norway : 1992)·2021

Same author

Female Genital Mutilation in Sudan: is a new era starting?

Sexuality & culture·2021

Same author

Child Undernutrition in Sudan: The Social and Economic Impact and Future Perspectives.

The American journal of tropical medicine and hygiene·2020

Same author

COVID-19, an Opportunity for Developing Countries?

Frontiers in public health·2020

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics.

Daniele Dionisio¹, Vincenzo Racalbuto, Daniela Messeri

¹"Access to Drugs: International Policies" - CLIA (Italian Network for International Fight against AIDS), Italian Society for Infectious and Tropical Diseases (SIMIT), Division of Infectious Diseases, Pistoia Hospital, Pistoia, Italy.

The Open AIDS Journal

|March 5, 2010

Summary

Patent pools for antiretroviral drugs (ARVs) are crucial for public health in underserved markets and should not be delayed. This strategy prioritizes health over profit, ensuring equitable access to essential medicines globally.

More Related Videos

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Published on: December 9, 2012

Related Experiment Videos

Last Updated: Jun 15, 2026

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Spatial Multiobjective Optimization of Agricultural Conservation Practices using a SWAT Model and an Evolutionary Algorithm

Published on: December 9, 2012

Area of Science:

Pharmaceutical policy
Intellectual property law
Global health equity

Background:

Patent pools for Fixed Dose Combination (FDC) antiretroviral drugs (ARVs) are essential for addressing urgent public health needs in underserved markets.
Originator companies express concerns that patent pooling may create exploitable opportunities for generic competitors, potentially undermining patent holder rights.

Purpose of the Study:

To analyze the concerns of the pharmaceutical brand industry regarding ARV patent pools.
To propose a strategy for an equitable global market that eliminates discrimination between end-users in high-income and resource-limited countries.
To advocate for prioritizing public health needs over profit-driven policies in ARV access.

Main Methods:

Analysis of originator company concerns regarding patent pooling for antiretroviral drugs.
Exploration of strategies to foster equitable access to medicines.
Review of international health policy recommendations and trade agreements.

Main Results:

Delayed patent pools for second and third-line FDC ARVs pose a significant risk to public health in underserved regions.
A proposed strategy involves initial partnerships between originator companies for rapid FDC ARV availability, followed by patent pool negotiations with generic manufacturers.
This approach aligns with global health recommendations and international trade principles against protectionism.

Conclusions:

Urgent implementation of patent pools for FDC ARVs is necessary to meet critical public health demands.
A collaborative strategy prioritizing health over profit can ensure equitable access to essential ARVs worldwide.
The proposed patent pool strategy supports global health equity and international trade commitments.